扩大壁细胞迷走神经切断术治疗十二指肠溃疡及其并发症

目的：评价扩大壁细胞迷走神经切断术（EPCV）治疗十二指肠溃疡及其并发症的远期临床疗效。方法：采用EPCV共治疗十二指肠溃疡及其并发症321例。其中慢性溃疡56例,并发急性穿孔204例,出血21例,狭窄40例。评价内容包括：术后并发症发生率、胃酸分泌功能、胃排空功能、胃镜和上消化道钡餐检查、营养状态、Visick分级。结果：全组321例患者中289例获得随访,随访率为90%,随访期为0.5-22.0年,平均为11.3年。全组无手术死亡,无纵隔炎和倾倒综合征发生。发生粘连性肠梗阻4例（1.4%）,进食后上腹胀19例（6.5%）,返酸17例（5.8%）,总的溃疡复发16例（5.5%）,其中慢性十二指肠溃疡为19.5%,出血为0,狭窄为5.3%,穿孔为3.1%。16例复发溃疡经内科药物治疗后溃疡愈合10例,其余6例经胃部分切除或胃窦切除痊愈。EPCV总的优良率（VisickⅠ和Ⅱ级）为91.7%,其中穿孔为95.3%,效果最佳。结论：EPCV具有手术操作简便、术后并发症较少、溃疡复发率低、术后远期患者营养状况良好、生活质量较高的特点,疗效优良。EPCV术是治疗十二指肠溃疡及其并发急性穿孔、出血和狭窄首选的安全有效术式。     

Highly selective vagotomy in duodenal ulceration and its complications. A 12-year review.

Highly selective vagotomy (HSV) was performed in 509 patients over 12 years for the surgical management of duodenal ulceration; 103 HSVs were carried out during the treatment of complications. The overall rate of ulcer recurrence was 7%, ranging from 10% in the first 4 years to 4% in the 6 years between 1975 and 1980. Highly selective vagotomy was performed in addition to closure of a perforated ulcer in 16 patients, with no recurrent ulcers or re-perforations. After the control of their bleeding duodenal ulcers, 25 patients had HSV with no rebleeding, although two patients had recurrent ulceration. Highly selective vagotomy was performed in 62 patients with stenosis in addition to dilatation (44) or duodenoplasty (18). There was a high incidence of recurrent ulceration (7) and stenosis (9) with digital dilatation while duodenoplasty gave better results with one recurrent stenosis and no recurrent ulceration. The authors conclude that HSV is justified by its late results as a definitive operation in chronic duodenal ulceration that allows preservation of the pylorus during surgery for complications.     

THE INTERRELATIONSHIP BETWEEN BLEEDING,PERFORATION, AND STENOSIS IN DUODENAL ULCERATION

The interrelationship of gastrointestinal bleeding, acute perforation, and pyloroduodenal stenosis was examined in a hospital series of 1,457 patients with duodenal ulcers. The proportion of each complication among the total number of ulcer patients after various periods of ulcer symptoms was determined. There was little variation in the proportion with bleeding as the duration of symptoms increased, whereas the proportion with perforation decreased and the proportion with stenosis increased with increasing duration of ulcer dyspepsia. The association of bleeding with perforation (26 patients) was more common than the association of bleeding with stenosis (12 patients), and more so than the association of perforation with stenosis (4 patients). To explain the paradoxical relationship of perforation and stenosis it was proposed that perforation occurred when the pathological process in ulceration was such that there was more tissue destruction than tissue repair, and that stenosis would result if there was more tissue repair than tissue destruction.     

Perforated duodenal ulcer in the black population of Central Johannesburg

The increasing incidence of perforated duodenal ulcer among Black patients admitted to the Johannesburg General Hospital between 1966 and 1976 is described against a background of the different forms of peptic ulcer disease seen in this hospital population. Admission for perforation during the years 1973-6 was as common among Black as among White patients. Perforation occurred principally in young (20-40 years) Black males (sex ratio 14 : 1), with a short history of preceding symptoms, and treatment was usually by simple closure. In the White group the age range was broader (20-70 years) and the male : female ratio only 2.7 : 1. Duodenal ulcer occurred predominantly in males (ratio 6 : 1), and the spectrum of the disease among the Black population in this urban environment resembled that among the White population in Johannesburg and in Western countries in the relative frequency of perforation and haemorrhage, rarity of stenosis and ratio of duodenal to gastric ulceration.     

The interrelationship between bleeding, perforation, and stenosis in duodenal ulceration.

The interrelationship of gastrointestinal bleeding, acute perforation, and pyloroduodenal stenosis was examined in a hospital series of 1,457 patients with duodenal ulcers. The proportion of each complication among the total number of ulcer patients after various periods of ulcer symptoms was determined. There was little variation in the proportion with bleeding as the duration of symptoms increased, whereas the proportion with perforation decreased and the proportion with stenosis increased with increasing duration of ulcer dyspepsia. The association of bleeding with perforation (26 patients) was more common than the association of bleeding with stenosis (12 patients), and more so than the association of perforation with stenosis (4 patients). To explain the paradoxical relationship of perforation and stenosis it was proposed that perforation occurred when the pathological process in ulceration was such that there was more tissue destruction. than tissue repair, and that stenosis would result if there was more tissue repair than tissue destruction     

Perforation in patients with bleeding ulcer

Twelve patients developed perforation after haemorrhage in a consecutive series of 840 cases admitted for bleeding chronic peptic ulcer. Death occurred in 3 of the 9 cases with duodenal ulcer and 1 of the 3 cases with gastric ulcer. There were 5 giant and 4 kissing duodenal ulcers and all 3 cases with gastric ulcer had a giant ulcer. The 12 patients were similar to the rest of the series in terms of ulcer site and shock on admission but were older and in poorer medical condition, more had ingested analgesics, more had giant ulcers and the mortality was greater (33% vs 6%). Giant ulceration was the only risk factor of potential clinical value as a predictor of the danger of ulcer perforation. One death occurred in 8 cases treated by early definitive surgery, suggesting this to be the treatment of choice for this unusual complication of peptic ulcer.     

Parietal cell vagotomy for duodenal and pyloric ulcers: I. Clinical factors leading to failure of the operation

In a prospective study, 170 consecutive unselected patients with duodenal (n = 115) or pyloric (n = 55) ulcers underwent elective parietal cell vagotomy, with an additional drainage procedure in patients with stenosis. The patients were classified in two consecutive groups and were followed up for 3 to 7 years after operation, in 132 cases for more than 5 years. The follow-up was complete. Patients with symptoms suggestive of ulcer for more than 3 days, independent of roentgenographic or endoscopic findings, were classified as having symptoms of recurrent ulcer and were specially analyzed.There was no mortality; splenic injuries occurred in 5 cases (3 percent), dumping symptoms in 4 percent after parietal cell vagotomy but in 34 percent after vagotomy plus drainage. Diarrhea occurred in 3 percent of the patients after parietal cell vagotomy and in 20 percent after vagotomy plus drainage.Fifty-five patients had clinical recurrences, significantly more patients with pyloric ulcer (46 percent) than with duodenal ulcer (28 percent). In 27 patients, the symptoms responded well to conservative therapy. In the other 28 patients the symptoms were severe, and 14 underwent reoperation for proven recurrent ulcers. The difference in the recurrence rates for duodenal and pyloric ulcer was found only in patients who did not undergo a drainage procedure, while pyloric ulcer patients with stenosis and a drainage operation were comparable in this respect to duodenal ulcer patients with and without drainage.A decrease in the rate of recurrence was achieved between the earlier and later parts of the series, even considering the difference in length of follow-up. The decrease is considered to reflect mainly our increased experience with the method. The results in patients in the later part of the series, followed up for more than 5 years, were a 22 percent incidence of recurrent ulcer symptoms and an 8 percent incidence of proven recurrent ulcers in those with duodenal ulcer, and a 28 percent incidence of recurrent ulcer symptoms and a 22 percent incidence of proven recurrent ulcers in those with pyloric ulcer.The overall results in patients followed up to more than 5 years, according to a modified Visick scale which incorporates differences in the severity of recurrent ulcer symptoms and the results after reoperation, were satisfactory in 89 percent of the patients with duodenal ulcer and in 73 percent of those with pyloric ulcer.     

Hemorrhagic gastro-duodenal ulcers. In which cases should emergency surgery be performed?]

From January 1983 to December 1987, 127 patients with bleeding peptic ulcer were admitted to hospital. The mean age of the 85 males was 57 years and 72 years for 42 females. All but four of the patients were managed medically after emergency endoscopy. Twenty-seven patients required surgical operations (21.2%): seven for cataclysmic haemorrhage, eight for persistent haemorrhage, twelve for recurrent bleeding. An analysis of factors leading to the necessity of surgical haemostasis was undertaken by considering the clinical status, endoscopic findings and laboratory results. The size of the ulcer (greater than 2 cm) was the most significant parameter (less than 0.01). Five other criteria (rectal bleeding) shock, endoscopic signs of recent haemorrhage, gastric or duodenal posterior ulcer) were also significant (p less than 0.05). Considering the gravity of these patients (six deaths among twenty-seven), clinical trials in bleeding peptic ulcer disease should only include patients in the high risk group.     

Clinical results and recurrences 1-4 years after parietal cell vagotomy in duodenal ulcer patients

168 patients with duodenal or prepyloric ulcer, treated with parietal cell vagotomy (PCV), were followed up one to four years after operation. 67% of the patients had more than 5 years' history of ulcer disease and in 44% preoperative bleeding or perforation could be confirmed. According to the modified Visick classification the clinical results were considered excellent or very good in 71%, with a marked tendency to better results for those surgeons with the greatest experience in performing parietal cell vagotomy. The result was considered unsatisfactory in 25 patients (15%) and this was in all cases due to reoperation and/or recurrent ulcer. There was no postoperative mortality and a low frequency of postoperative complications. Dumping was found in only one patient and mild diarrhoea in two. At follow-up, 16 patients (9.5%) had had a proven and 8 (4.5%) a suspected recurrent ulcer and 3 had gastric retention without recurrence. The recurrence rate was very high for those patients operated during the first year after the introduction of PCV, but then decreased significantly. 18 patients required reoperation. Antrectomy or truncal vagotomy with drainage is considered the method of choice for patients with an incomplete PCV and recurrent ulcer.     

Highly selective vagotomy 5-15 years on

Highly selective vagotomy for duodenal ulcer was performed on 307 patients between 1973 and 1983 without operative mortality. Of these, 283 (92.2 per cent) were followed up prospectively for a minimum of 5 years. Recurrent ulcer was diagnosed in 49 (17.3 per cent). The recurrent ulcer rate increased from 13.2 per cent at 5 years to 19.4 per cent at 12 years. Age, length of history, previous haemorrhage or perforation and preoperative acid output were not associated with increased risk of recurrent ulceration. The risk in men and smokers was higher but not significantly so. The recurrence rate for individual surgeons varied from 5.3 to 25.6 per cent. Failure of healing with H2-receptor antagonists was not associated with a higher recurrent ulcer rate. Patients with a strong family history (more than one first degree relative affected) had a significantly higher recurrence rate (33.2 per cent at 10 years) than those without (13.5 per cent at 10 years). Of the 49 recurrent ulcer patients, 30 (61.2 per cent) required either an operation or regular H2-receptor antagonists. Of the 250 patients (81.4 per cent) available in 1988 for review of symptoms 5-15 years after operation, 5.4 per cent had dumping, 8.9 per cent epigastric pain, and 11.8 per cent heartburn every day or most days. H2-receptor antagonists were required by 10.7 per cent of patients on a frequent or regular basis. Of 239 patients who answered the question, 218 (91.2 per cent) felt that their symptoms had been cured or greatly improved and 203 (84.9) considered the operation a success. Despite the high recurrence rate, the operation was successful in controlling ulcer symptoms in around 90 per cent of patients and produced postvagotomy symptoms--none severe--in around 5 per cent of patients.     

Highly selective vagotomy--a safe operation for duodenal ulcer. Immediate and long-term complications and sequelae in 500 patients.

The safety and efficacy of highly selective vagotomy were assessed in a prospective series of 500 patients who underwent the operation during a 15-year period. There was no peroperative or immediate postoperative mortality. None of the 22 late deaths was attributable to the operation. In six cases complications prolonged the hospital stay beyond 21 days, requiring a second laparotomy in four. The rate of ulcer recurrence was 18.5% by 15 years. Bloating was the commonest long-term complication (8.8%), but half of these patients regarded the operation as successful. Less common were dumping (5.4%), diarrhoea (3.8%) and gastric stasis (1.4%). Revisional surgery was performed on 37 patients--for recurrent ulcer in 28, for gastric stasis in seven and for perforation in two. Although almost 20% of the reviewed patients continue to require regular or frequent medication, the study shows that highly selective vagotomy can be therapeutically effective for duodenal ulcer, particularly in preventing haemorrhage and perforation in patients who have previously suffered these complications. Above all it is a safe operation with low long-term morbidity.     

Bleeding gastroduodenal ulcer: results of surgical management

AIM OF THE STUDY: The aim of this retrospective study was to report the mortality and morbidity after surgery for bleeding peptic ulcer while the population is aging and while the medical treatment and endoscopic procedures are improving. PATIENTS AND METHODS: This retrospective study between 1994 and 1999 included 49 patients, 15 women, 34 men, aged 72 +/- 14 years. Patients were separated into three groups: ten with uncontrollable haemorrhages, 28 with recurrent haemorrhages and 11 with persistent haemorrhages. These patients were classified ASA II (n = 6), ASA III (n = 20), ASA IV (n = 21) and ASA V (n = 2). The surgical procedures for gastric ulcers (n = 5) were resection-oversewing (n = 2) or partial gastric resection (n = 3). The surgical procedures for duodenal ulcers (n = 44) were oversewing (n = 30), partial gastric resection (n = 10) or exploratory duodenotomy (n = 4). RESULTS: The overall postoperative mortality rate was 20.4% (10/49). The mortality rate was 40% (4/10) in patients with massive haemorrhage, 7% (2/28) in patients with recurrent haemorrhage, and 36% (4/11) in patients with persistent haemorrhage. There was no significant difference in the mortality rate in relation to the surgical procedures. The morbidity rate was 45%, including three bleeding recurrences after suture and three duodenal leakages after partial gastric resection. CONCLUSION: The morbidity and mortality rate after surgery for bleeding peptic ulcer is still high. Recurrent haemorrhages don't worsen the prognosis. Delayed surgery for persistent haemorrhage is associated with a severe prognosis.     

逆行游离高选择性胃迷走神经切断术治疗十二指肠溃疡

目的：探讨逆行游离高选择性胃迷走神经切断术治疗十二指肠溃疡的可行性和有效性,评估该术式的远期效果,为临床治疗提出新思路。方法：应用逆行游离高选择性胃迷走神经切断术治疗十二指肠溃疡主其工发穿孔、出血和狭窄患者70例,其溃疡穿孔61例,出血6例,狭窄3。结果：65例患者获得访,总的溃复发率为7.69%,再出血率为0。随访30-120个月,属改良VisickⅠ级56例占86.2%,Ⅱ级4例占6.1%,Ⅲ级2例占3.0%,Ⅳ级3例占4.6%,Ⅰ、Ⅱ级共占92.3%。结论：逆行游离高选择性胃迷走神经切断术治疗十二指肠溃疡及其并发症,具有缩短手术时间、简化手术操作、患者远期预后好等优点,可作为治疗十二指肠溃疡合并症的一种有效的方法。     

Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies

BACKGROUND: The possible advantage of eradication of Helicobacter pylori in patients with perforated duodenal ulcer is unknown. This study was planned to assess the prevalence of H. pylori after simple closure of a perforated duodenal ulcer and to study the effect of H. pylori eradication on ulcer persistence and recurrence. METHODS: Some 202 patients were followed prospectively for 2 years after simple closure of a perforated duodenal ulcer (prospective group). A second group of 60 patients was reviewed 5 years or more after perforation closure (retrospective group). The prevalence of H. pylori in patients with perforated duodenal ulcer was compared with that in controls. Patients in the prospective group were randomized to receive either ranitidine alone or quadruple therapy (ranitidine, colloidal bismuth subcitrate, metronidazole and tetracycline) after operation. The incidence of H. pylori infection after the two treatments and the association with residual or recurrent ulcer were studied. In the retrospective group long-term ulcer recurrence was correlated with H. pylori status. RESULTS: The prevalence of H. pylori in patients with perforated duodenal ulcer was not significantly different from that in controls. At every interval of follow-up in the prospective group and in the retrospective group the H. pylori infection rate was significantly higher in patients who had recurrent or residual ulcers. CONCLUSION: Eradication of H. pylori after simple closure of a perforated duodenal ulcer should reduce the incidence of residual and recurrent ulcers.     

Vagotomy and antrectomy revisited

A retrospective review of 185 patients who underwent truncal vagotomy and antrectomy for duodenal ulcer disease was carried out to determine the mortality and morbidity of the procedure. There were no deaths within 30 days of operation and only one patient died while in the hospital (0.54%). Twenty-one patients (11.4%) suffered early morbidity, 3 of them requiring a second operation. Follow-up was obtained in 83 patients and averaged 13.5 years. According to Visick's classification 75 patients (90.4%) were in class I or II; 5 patients (6%) were in class III and 3 patients (3.6%) in class IV. A recurrent ulcer developed in 2 of the 83 patients. In contrast, after highly selective vagotomy, the literature supports an unacceptable incidence of recurrent ulcer. Therefore, we must not prematurely cast aside vagotomy and antrectomy; it still remains a safe and acceptable procedure for duodenal ulcer disease.     

Surgeons'' attitudes to the operative management of duodenal ulcer perforation and haemorrhage.

The currently preferred operative management of duodenal ulcer haemorrhage and perforation was assessed by means of a questionnaire sent to 274 consultant general surgeons in England. A 70% response rate was achieved. Simple closure, with or without H2 antagonist treatment, was the most popular management of a perforated acute duodenal ulcer. For perforation of a chronic duodenal ulcer occurring during H2 antagonist therapy, truncal vagotomy and drainage was the definitive procedure of choice. There was no consensus about the operative management of perforation complicating non-steroidal anti-inflammatory drug treatment in the elderly patient. Proximal gastric vagotomy appears to have few advocates in the definitive management of either duodenal ulcer perforation or haemorrhage. Of our sample 70% selected truncal vagotomy and drainage with underrunning of the ulcer as the operative treatment of choice for bleeding. Endoscopic coagulation appears to be used only rarely.     

Late results of perforated duodenal ulcer treated by simple suture

A study was performed of 156 patients who underwent follow-up evaluations 3 to 23 years (mean 13 years) after simple closure of a perforated duodenal ulcer. Subsequent definitive ulcer surgery was indicated in 111 patients (71%) for severe recurrent dyspepsia. Bleeding, reperforation or pyloric obstruction occurred in 14 patients (9%). Among 33 patients (21%) with an ulcer history of less than 3 months prior to perforation, only 4 (12%) required further surgery while a subsequent operation was indicated in 107 of 123 patients with a longer ulcer history. Immediate definitive surgery is indicated for perforated duodenal ulcer in patients with ulcer symptoms for more than 3 months before perforation. Simple suture of the perforation is sufficient treatment for patients with a shorter ulcer history.

---

Résumé Cent cinquante six malades opérés de simple raphie pour ulcère duodenal perforé ont été suivis pendant 3–23 ans (moyenne 13 ans). Chez lll d'entre eux (71%), une opération curative a dû être faite pour récidive des symptômes d'ulcère. Quatorze malades (9 %) ont présenté une hémorragie, une deuxième perforation ou une sténose pylorique. Les antécédents d'ulcère avant la perforation remontaient à moins de 3 mois chez 33 patients (21 %) : 4 (12 %) seulement ont dû être réopérés alors que 107 des 123 malades ayant une histoire plus longue ont dû subir une deuxième intervention. En cas d'ulcère duodenal perforé, la chirurgie d'emblée curatrice est donc indiquée chez les malades ayant des antécédents de plus de trois mois; pour les autres, la simple raphie suffit.

     

扩大壁细胞迷走神经切断术治疗十二指肠溃疡急性穿孔176例

目的探讨扩大壁细胞迷走神经切断术（EPCV）治疗十二指肠溃疡并发急性穿孔的远期临床疗效。方法对1979年以来采用EPCV治疗的176例十二指肠溃疡并发急性穿孔患者的临床资料进行总结,分析评价疗效,评价内容包括术后并发症发生率、溃疡复发率、胃排空功能、胃镜和上消化道钡餐检查结果和营养状态及Visick分级。结果全组患者有153例（86.9%）获得5年随访。无手术死亡者。进食后上腹发生间断性胀痛13例（8.5%）,有时返酸12例（7.8%）,经服用吗叮啉可缓解。出现粘连性肠梗阻行粘连松解术4例（2.6%）,溃疡复发4例（2.6%）,均发生在术后2-3年内。浅表性胃炎21例（13.7%）,十二指肠球部变形31例（20.3%）,胃窦蠕动功能较好,胃排空功能正常。全组无贫血发生,体重增加者116例（75.8%）。Visick改良分级,146例为Ⅰ级和Ⅱ级,优良率占95.4%,Ⅲ级3例（2.0%）,Ⅳ级4例（2.6%）。结论EPCV术具有手术操作简便、术后并发症较少、溃疡复发率低、患者术后远期营养状况良好、生活质量较高的优良疗效,是治疗十二指肠溃疡并发急性穿孔首选的安全有效术式之一。     

Surgery for duodenal ulcer. A study relating indications to the results of surgery.

The present study correlates the indications for operation in 215 patients with duodenal ulcer disease with the results of operative management. The majority of patients had conservative surgery utilizing truncal vagotomy and pyloroplasty or gastrojejunostomy. None of the 194 patients operated on electively died and four patients died after emergency operations, for an overall operative mortality in the entire series of 1.8 per cent. The incidence of recurrent ulcer symptoms in all patients was 10 per cent. We could demonstrate only a modest correlation between indications for operation and long-term results of conservative surgical management; the indication for surgery, whether that of chronic (intractability, stenosis) or more acute (hemorrhage, perforation) ulcer disease is only moderately reliable as a predictor of long-term results. In this series of patients, those with obstructing duodenal ulcers (pyloric stenosis) had the best long-term results after conservative surgical management.     

Long-term clinical results of highly selective vagotomy performed between 1980 and 1990

A retrospective analysis was conducted of 778 patients who underwent highly selective vagotomy between 1980 and 1990. Surgery was performed for duodenal ulcers without any complications in 485 (62.3%) patients; for duodenal ulcers with complications such as stenosis, bleeding, or perforation in 270 (34.7%); for combined duodenal and ventricular ulcers in 12 (1.5%), and for ventricular ulcers alone in 11 (1.4%). Pyloroplasty was additionally performed in the presence of complications only. The incidence of intraoperative complications proved to be as high as 1.4%, occurring in 11 patients, while postoperative complications developed in 247 patients (31.7%). Although the overall mortality was 0.6% (5 patients), the mortality rate of those patients who underwent surgery for uncomplicated ulcer disease was 0.2% only (2 patients). The patients comprised 554 men (71.2%) and 224 women (28.8%) with an average age of 41.4±0.7 years. The average duration of duodenal ulcer disease was 9.5 years, and 643 (83.2%) of the patients were able to be regularly followed up for between 3 and 13 years. Recurrence developed in 62 patients (9.6%): in the duodenum in 57 patients (91.9%), and in the stomach in 5 (8.1%). The rate of recurrence according to sex was 9.4% in men and 10.3% in women, being 42 and 20 patients, respectively. The average duration until recurrence appeared was 27.06±3.44 months. A reoperation proved necessary in 28 of these 62 patients (45.1%). The clinical results were evaluated by means of a modified Visick classification, according to which 81.8% of the patients belonged to groups 1 or 2, 7.9% to group 3, and 10.3% to group 4.